Business Context and Reporting Period
This Form 8-K is a current report filed by Shuttle Pharmaceuticals Holdings, Inc. on April 29, 2024. The filing primarily addresses Item 8.01 (Other Events) regarding an upcoming investor presentation.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is an event notification and does not contain financial statements or updated financial data.
Material Changes
No material financial changes or operational updates are reported in this document. The filing serves to disclose a scheduled corporate event rather than a change in the company's financial condition.
Guidance, Outlook, and Events
- Upcoming Event: CEO Dr. Anatoly Dritschilo is scheduled to present at the Planet MicroCap Showcase: VEGAS 2024 on May 1, 2024, at 4:30 pm PT (7:30 pm ET) at the Paris Hotel & Casino in Las Vegas.
- Investor Presentation: An updated investor presentation has been prepared for the event and is available on the company's website.
- Forward-Looking Statements: The filing includes standard disclaimers that forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from expectations.
Key Facts for Investor Verification
- Verify the date and time of the CEO's presentation at the Planet MicroCap Showcase (May 1, 2024).
- Review the attached Exhibit 99.1 (Investor Presentation) for updated strategic details, noting that this exhibit is furnished and not deemed "filed" under the Exchange Act.
- Consult the company's most recent Form 10-K or 10-Q for actual financial performance data, as this 8-K contains no financial figures.